Chiron Real Estate Inc. (XRN) - Q2 2026 Filing Summary
Business Context and Reporting Period
This Form 10-Q covers the quarterly period ended June 30, 2026. Chiron Real Estate Inc. is an internally managed REIT owning healthcare facilities and seniors housing communities. As of June 30, 2026, the portfolio consisted of 82% healthcare facilities, 16% seniors housing operating portfolio (SHOP) assets, and 2% unconsolidated joint ventures. The Company is actively transitioning its strategy to focus on seniors housing, evidenced by the establishment of a SHOP segment effective in Q2 2026.
Key Financial Metrics
| Metric | Q2 2026 (3 Months) | YTD 2026 (6 Months) | Q2 2025 (3 Months) | YTD 2025 (6 Months) |
|---|---|---|---|---|
| Total Revenue | $39.7 million | $77.8 million | $38.0 million | $72.6 million |
| Net Income | $72.3 million | $73.9 million | $0.6 million | $4.3 million |
| Net Income Attributable to Common Stockholders | $63.3 million | $62.5 million | $(0.8) million | $1.3 million |
| Diluted EPS (Common) | $4.78 | $4.73 | $(0.06) | $0.10 |
| Net Operating Income (NOI) | $29.7 million | $58.5 million | $29.8 million | $56.9 million |
| FFO (Common & NCI) | $12.7 million | $26.8 million | $14.3 million | $29.0 million |
| Cash & Equivalents | $10.7 million | $10.7 million | $6.6 million | $6.6 million |
| Total Debt (Credit Facility + Notes) | $633.1 million | $633.1 million | $653.9 million | $653.9 million |
Note: Net Income for 2026 includes a significant non-recurring gain on the sale of investment properties.
Material Changes vs. Prior Period
- Significant Gain on Sale: Net income surged primarily due to a $71.9 million gain recognized from the sale of seven inpatient rehabilitation facilities (IRFs) to a newly formed joint venture (IRF Joint Venture) on June 29, 2026. This transaction generated net proceeds of $211.4 million before funding a $16.3 million retained equity investment.
- Acquisitions: The Company acquired two luxury seniors housing communities in Alexandria, Virginia (The Landing and The Riviera) on June 1, 2026, for approximately $249 million combined. These assets contributed $1.8 million in resident fees and services revenue in Q2 2026.
- Segment Restructuring: Effective Q2 2026, the Company adopted two reportable segments: Healthcare Real Estate and SHOP. The SHOP segment, previously non-existent, now accounts for 100% of resident fee revenue.
- Dividend Reduction: On May 5, 2026, the Board reduced the common stock dividend from $0.25 per share (quarterly equivalent) to $0.16 per share (monthly) to retain cash for acquisitions and portfolio ramp-up.
- Interest Expense: Interest expense increased to $8.8 million in Q2 2026 from $8.0 million in Q2 2025, driven by higher interest rates following the expiration of prior interest rate swaps and the replacement with new swaps at higher fixed SOFR rates (3.24% to 3.32%).
Guidance, Outlook, and Risks
- Capital Raising: The Company raised $100 million in gross proceeds via a private placement of Series C Convertible Preferred Stock in May/June 2026. Proceeds were used to fund the Alexandria acquisitions.
- Strategic Focus: Management is pivoting to seniors housing, citing demographic trends and improving profitability in the sector. The Company has $288 million remaining under its 2024 ATM program and $245.5 million of unutilized capacity on its Credit Facility as of August 3, 2026.
- Key Risks:
- SHOP Operational Risk: Direct participation in seniors housing operations exposes the Company to occupancy fluctuations, labor costs, and regulatory liabilities not present in its legacy triple-net lease portfolio.
- Interest Rate Sensitivity: $141 million of unhedged borrowings remain exposed to variable rates. A 100 basis point increase in SOFR would decrease annual cash flow by approximately $1.4 million.
- Tenant Concentration: While no single tenant exceeds 10% of revenue, the Company faces risks related to the bankruptcy of White Rock Medical Center (Dallas), which has filed for Chapter 11 protection.
Investor Verification Checklist
- Gain Sustainability: Verify the non-recurring nature of the $71.9 million gain on the IRF sale and assess core operating performance (FFO/Core FFO) excluding this item.
- Dividend Coverage: Confirm the sustainability of the reduced dividend rate ($0.16/month) against the new capital structure and increased preferred dividend obligations (Series C).
- SHOP Performance: Monitor occupancy and fee growth for the newly acquired Landing and Riviera communities, as they are in the lease-up phase.
- Debt Covenants: Review compliance with the Credit Facility covenants, specifically the maximum consolidated leverage ratio (60%) and minimum fixed charge coverage ratio (1.50:1.00).
- White Rock Exposure: Assess the collectability of the $1.7 million receivable from White Rock Medical Center and the likelihood of lease affirmation in their reorganization plan.